<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28430790</article-id>
<article-id pub-id-type="pmc">5400231</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0173944</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-41740</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Neurodegenerative Diseases</subject>
<subj-group>
<subject>Movement Disorders</subject>
<subj-group>
<subject>Parkinson Disease</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Schizophrenia</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Database and Informatics Methods</subject>
<subj-group>
<subject>Biological Databases</subject>
<subj-group>
<subject>Genomic Databases</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genomic Databases</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genomic Databases</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetic Loci</subject>
<subj-group>
<subject>Alleles</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Proteins</subject>
<subj-group>
<subject>Cytoskeletal Proteins</subject>
<subj-group>
<subject>Microtubule-Associated Proteins</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetics of Disease</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Mutation</subject>
<subj-group>
<subject>Deletion Mutation</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson’s disease</article-title>
<alt-title alt-title-type="running-head">22q11.2 deletion-associated PD mechanisms</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Butcher</surname>
<given-names>Nancy J.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="currentaff001">
<sup>¤</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Merico</surname>
<given-names>Daniele</given-names>
</name>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zarrei</surname>
<given-names>Mehdi</given-names>
</name>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogura</surname>
<given-names>Lucas</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marshall</surname>
<given-names>Christian R.</given-names>
</name>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chow</surname>
<given-names>Eva W. C.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Anthony E.</given-names>
</name>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff007">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff008">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="aff009">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scherer</surname>
<given-names>Stephen W.</given-names>
</name>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bassett</surname>
<given-names>Anne S.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff011">
<sup>11</sup>
</xref>
<xref ref-type="aff" rid="aff012">
<sup>12</sup>
</xref>
<xref ref-type="aff" rid="aff013">
<sup>13</sup>
</xref>
<xref ref-type="aff" rid="aff014">
<sup>14</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001">
<label>1</label>
<addr-line>Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff002">
<label>2</label>
<addr-line>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff003">
<label>3</label>
<addr-line>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff004">
<label>4</label>
<addr-line>The Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff005">
<label>5</label>
<addr-line>McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff006">
<label>6</label>
<addr-line>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff007">
<label>7</label>
<addr-line>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff008">
<label>8</label>
<addr-line>Tanz Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff009">
<label>9</label>
<addr-line>Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff010">
<label>10</label>
<addr-line>Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff011">
<label>11</label>
<addr-line>Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff012">
<label>12</label>
<addr-line>The Dalglish 22q Clinic for Adults with 22q11.2 Deletion Syndrome, University Health Network, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff013">
<label>13</label>
<addr-line>Department of Psychiatry, University Health Network, Toronto, Ontario, Canada</addr-line>
</aff>
<aff id="aff014">
<label>14</label>
<addr-line>Division of Cardiology, Department of Medicine, University Health Network, Toronto, Ontario, Canada</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Galli</surname>
<given-names>Alvaro</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>CNR, ITALY</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>Dr. Butcher received a training award from Brain Canada and Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship. Dr. Merico receives Science and Technology Innovation Centre funding from Genome Canada/Ontario Genomics Institute. Dr. Zarrei reports no disclosures. Mr. Ogura reports no disclosures. Dr. Marshall reports no disclosures. Dr. Chow receives research support from the National Institutes of Health (NIH; 5U01MH101723-02). Dr. Lang receives research support from Brain Canada, Canadian Institutes of Health Research (CIHR), Edmond J. Safra Philanthropic Foundation, Michael J. Fox Foundation, National Parkinson Foundation, Ontario Brain Institute, Parkinson Society Canada, Tourette Syndrome Association, W. Garfield Weston Foundation; honoraria from Medtronic, Teva, UCB, AbbVie; royalties from Saunders, Wiley-Blackwell, Johns Hopkins Press, Cambridge University Press; and acted as an advisor to Abbvie, Allon Therapeutics, Avanir Pharmaceuticals, Biogen Idec, Boerhinger-Ingelheim, Bristol-Myers Squibb, Ceregene, Lilly, Medtronic, Merck, Novartis, Teva, and UCB and as an expert witness in cases related to the welding industry. Dr. Scherer serves on the Scientific Advisory Board of Population Diagnostics and is a co-founder of YouNique Genomics. Dr. Bassett receives research support from CIHR (MOP #97800, MOP #111238), the Canada Research Chairs in Schizophrenia Genetics and Genomic Disorders, the Dalgish Chair, the NIH (5U01MH101723-02), and the University of Toronto McLaughlin Centre (MC-2014-01). This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> NJB DM CRM EWCC AEL SWS ASB.</p></list-item><list-item><p><bold>Data curation:</bold> NJB DM MZ LO CRM ASB.</p></list-item><list-item><p><bold>Formal analysis:</bold> NJB DM MZ LO CRM.</p></list-item><list-item><p><bold>Funding acquisition:</bold> NJB DM ASB.</p></list-item><list-item><p><bold>Investigation:</bold> NJB DM MZ LO CRM.</p></list-item><list-item><p><bold>Methodology:</bold> NJB DM CRM SWS ASB.</p></list-item><list-item><p><bold>Project administration:</bold> NJB DM CRM SWS ASB.</p></list-item><list-item><p><bold>Resources:</bold> EWCC AEL SWS ASB.</p></list-item><list-item><p><bold>Software:</bold> NJB DM MZ LO CRM.</p></list-item><list-item><p><bold>Supervision:</bold> ASB.</p></list-item><list-item><p><bold>Visualization:</bold> NJB.</p></list-item><list-item><p><bold>Writing – original draft:</bold> NJB DM ASB.</p></list-item><list-item><p><bold>Writing – review &amp; editing:</bold> NJB DM CRM EWCC AEL SWS ASB.</p></list-item></list>
</p>
</fn>
<fn fn-type="current-aff" id="currentaff001">
<label>¤</label>
<p>Current address: Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America</p>
</fn>
<corresp id="cor001">* E-mail: <email>anne.bassett@utoronto.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>4</issue>
<elocation-id>e0173944</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>3</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Butcher et al</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Butcher et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0173944.pdf"></self-uri>
<abstract>
<sec id="sec001">
<title>Objectives</title>
<p>To investigate disease risk mechanisms of early-onset Parkinson’s disease (PD) associated with the recurrent 22q11.2 deletion, a genetic risk factor for early-onset PD.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>In a proof-of-principle study, we used whole-genome sequencing (WGS) to investigate sequence variants in nine adults with 22q11.2DS, three with neuropathologically confirmed early-onset PD and six without PD. Adopting an approach used recently to study schizophrenia in 22q11.2DS, here we tested candidate gene-sets relevant to PD.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>No mutations common to the cases with PD were found in the intact 22q11.2 region. While all were negative for rare mutations in a gene-set comprising PD disease-causing and risk genes, another candidate gene-set of 1000 genes functionally relevant to PD presented a nominally significant (<italic>P</italic> = 0.03) enrichment of rare putatively damaging missense variants in the PD cases. Polygenic score results, based on common variants associated with PD risk, were non-significantly greater in those with PD.</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>The results of this first-ever pilot study of WGS in PD suggest that the cumulative burden of genome-wide sequence variants may contribute to expression of early-onset PD in the presence of threshold-lowering dosage effects of a 22q11.2 deletion. We found no evidence that expression of PD in 22q11.2DS is mediated by a recessive locus on the intact 22q11.2 chromosome or mutations in known PD genes. These findings offer initial evidence of the potential effects of multiple within-individual rare variants on the expression of PD and the utility of next generation sequencing for studying the etiology of PD.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000024</institution-id>
<institution>Canadian Institutes of Health Research</institution>
</institution-wrap>
</funding-source>
<award-id>97800</award-id>
<principal-award-recipient>
<name>
<surname>Bassett</surname>
<given-names>Anne S.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000024</institution-id>
<institution>Canadian Institutes of Health Research</institution>
</institution-wrap>
</funding-source>
<award-id>111238</award-id>
<principal-award-recipient>
<name>
<surname>Bassett</surname>
<given-names>Anne S.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by the Canadian Institutes of Health Research (A.S.B, MOP #97800, MOP #111238), Canada Research Chairs program (A.S.B), a Brain Canada Mental Health Training Award (N.J.B), a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship (N.J.B), and Science and Technology Innovation Centre funding from Genome Canada/Ontario Genomics Institute (D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="3"></table-count>
<page-count count="14"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data are deposited at the European Genome-phenome Archive (EGA) under the following accession numbers: Study EGAS00001002275; Dataset EGAD00001003187.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>Data are deposited at the European Genome-phenome Archive (EGA) under the following accession numbers: Study EGAS00001002275; Dataset EGAD00001003187.</p>
</notes>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Over the past two decades new knowledge has elucidated a genetic basis for an increasing proportion of patients with Parkinson’s disease (PD) [<xref ref-type="bibr" rid="pone.0173944.ref001">1</xref>]. We identified the hemizygous 22q11.2 microdeletion associated with 22q11.2 deletion syndrome (22q11.2DS; OMIM #192430, #188400) as a novel genetic risk factor for neuropathologically confirmed, L-dopa responsive early-onset PD [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]. This structural variant has since been found to be significantly enriched in early-onset PD cohorts and may account for ~0.5% of cases [<xref ref-type="bibr" rid="pone.0173944.ref003">3</xref>]. Genetic variants on the intact 22q11.2 chromosome, or genome-wide outside of the deletion region, may influence the likelihood of expression of PD in 22q11.2DS. Using this genetic model to identify such variants could provide clues to variants that affect susceptibility to idiopathic forms of PD and general disease mechanisms.</p>
<p>As a proof-of-principle to assess this model, we used whole-genome sequencing (WGS) data, adapting a strategy successfully used to study expression of schizophrenia in 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>]. We compared variants from 22q11.2DS patients with early-onset PD [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>] to those without PD. To maximize statistical power in this initial study, we investigated rare variant burden for gene-sets with higher a priori likelihood of contributing to PD risk. These included variants affecting candidate genes in the 22q11.2 deletion region, such as <italic>COMT</italic>, <italic>SEPT5</italic>, and six mitochondrial function genes, as well as other genome-wide PD-relevant gene-sets. We also investigated common variant contribution using a polygenic risk score model. We found evidence for rare variants outside the 22q11.2 region perturbing gene networks relevant to PD, supporting the utility of this genetic model for early-onset PD.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Subjects</title>
<p>We performed WGS using DNA from nine unrelated adults of European descent with chromosome 22q11.2 deletions [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>] (<xref ref-type="table" rid="pone.0173944.t001">Table 1</xref>) selected from a cohort of Canadian adults with 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0173944.ref008">8</xref>]. Direct clinical assessments at multiple timepoints and review of comprehensive lifetime medical records and clinical histories provided deep phenotyping using our established methods [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0173944.ref008">8</xref>]. The three subjects with early-onset PD (PD1-PD3) met United Kingdom Parkinson’s Disease Society Brain Bank clinical diagnostic criteria and had confirmed PD neuropathology [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]. We had previously reported that these 22q11.2DS-PD patients had no known pathogenic point mutations in <italic>LRRK2</italic>, <italic>PARK2</italic>, <italic>DJ-I</italic>, <italic>PINK1</italic>, or <italic>SNCA</italic>, or copy number variants in <italic>PARK2</italic> or <italic>SNCA</italic> [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>].</p>
<table-wrap id="pone.0173944.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173944.t001</object-id>
<label>Table 1</label>
<caption>
<title>Clinical and 22q11.2 deletion-related characteristics of individuals with 22q11.2 deletion syndrome of European Ancestry with whole-genome sequencing results.</title>
</caption>
<alternatives>
<graphic id="pone.0173944.t001g" xlink:href="pone.0173944.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1"></th>
<th align="center" colspan="3" rowspan="1">22q11.2DS-Parkinson’s disease</th>
<th align="center" colspan="6" rowspan="1">22q11.2DS-No Parkinson’s disease</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<italic>Subject identifier</italic>
</th>
<th align="right" colspan="1" rowspan="1">PD1</th>
<th align="right" colspan="1" rowspan="1">PD2</th>
<th align="right" colspan="1" rowspan="1">PD3</th>
<th align="right" colspan="1" rowspan="1">NPD1</th>
<th align="right" colspan="1" rowspan="1">NPD2</th>
<th align="right" colspan="1" rowspan="1">NPD3</th>
<th align="right" colspan="1" rowspan="1">NPD4</th>
<th align="right" colspan="1" rowspan="1">NPD5</th>
<th align="right" colspan="1" rowspan="1">NPD6</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="9" rowspan="1">
<bold>
<italic>Demographic features and PD phenotype</italic>
</bold>
</td>
<td align="right" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sex</td>
<td align="right" colspan="1" rowspan="1">Female</td>
<td align="right" colspan="1" rowspan="1">Male</td>
<td align="right" colspan="1" rowspan="1">Male</td>
<td align="right" colspan="1" rowspan="1">Female</td>
<td align="right" colspan="1" rowspan="1">Male</td>
<td align="right" colspan="1" rowspan="1">Female</td>
<td align="right" colspan="1" rowspan="1">Male</td>
<td align="right" colspan="1" rowspan="1">Male</td>
<td align="right" colspan="1" rowspan="1">Female</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (y)</td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    At last follow-up or at death</td>
<td align="right" colspan="1" rowspan="1">56</td>
<td align="right" colspan="1" rowspan="1">58</td>
<td align="right" colspan="1" rowspan="1">61</td>
<td align="right" colspan="1" rowspan="1">21</td>
<td align="right" colspan="1" rowspan="1">38</td>
<td align="right" colspan="1" rowspan="1">48</td>
<td align="right" colspan="1" rowspan="1">44</td>
<td align="right" colspan="1" rowspan="1">53</td>
<td align="right" colspan="1" rowspan="1">52</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    PD motor symptom onset</td>
<td align="right" colspan="1" rowspan="1">45</td>
<td align="right" colspan="1" rowspan="1">48</td>
<td align="right" colspan="1" rowspan="1">43</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    PD diagnosis</td>
<td align="right" colspan="1" rowspan="1">55</td>
<td align="right" colspan="1" rowspan="1">54</td>
<td align="right" colspan="1" rowspan="1">44</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
<td align="right" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Family history of PD</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Father, late-onset</td>
<td align="right" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neuropathology<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
<td align="right" colspan="1" rowspan="1">Nigral cell death, LBs [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]</td>
<td align="right" colspan="1" rowspan="1">Nigral cell death, LBs [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]</td>
<td align="right" colspan="1" rowspan="1">Nigral cell death<break></break> [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]</td>
<td align="right" colspan="1" rowspan="1">Living</td>
<td align="right" colspan="1" rowspan="1">Living</td>
<td align="right" colspan="1" rowspan="1">Living</td>
<td align="right" colspan="1" rowspan="1">No PD pathology [<xref ref-type="bibr" rid="pone.0173944.ref010">10</xref>]</td>
<td align="right" colspan="1" rowspan="1">Living</td>
<td align="right" colspan="1" rowspan="1">Living</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold><italic>Other 22q11</italic>.<italic>2DS features</italic></bold>
</td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital heart defect</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Intellectual disability</td>
<td align="right" colspan="1" rowspan="1">Borderline</td>
<td align="right" colspan="1" rowspan="1">None</td>
<td align="right" colspan="1" rowspan="1">None</td>
<td align="right" colspan="1" rowspan="1">Mild</td>
<td align="right" colspan="1" rowspan="1">Mild</td>
<td align="right" colspan="1" rowspan="1">Borderline</td>
<td align="right" colspan="1" rowspan="1">Borderline</td>
<td align="right" colspan="1" rowspan="1">Borderline</td>
<td align="right" colspan="1" rowspan="1">Borderline</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Schizophrenia (age at onset, y)</td>
<td align="right" colspan="1" rowspan="1">Yes (17)</td>
<td align="right" colspan="1" rowspan="1">Yes (22)</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes (12)</td>
<td align="right" colspan="1" rowspan="1">Yes (15)</td>
<td align="right" colspan="1" rowspan="1">Yes (18)</td>
<td align="right" colspan="1" rowspan="1">Yes (21)</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other psychiatric disorder<xref ref-type="table-fn" rid="t001fn004"><sup>c</sup></xref></td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Seizures<xref ref-type="table-fn" rid="t001fn005"><sup>d</sup></xref></td>
<td align="right" colspan="1" rowspan="1">Single</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">Recurrent</td>
<td align="right" colspan="1" rowspan="1">Recurrent</td>
<td align="right" colspan="1" rowspan="1">Recurrent</td>
<td align="right" colspan="1" rowspan="1">Single</td>
<td align="right" colspan="1" rowspan="1">No</td>
<td align="right" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold><italic>22q11</italic>.<italic>2 deletion region</italic></bold>
</td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Deletion type<xref ref-type="table-fn" rid="t001fn006"><sup>e</sup></xref></td>
<td align="right" colspan="1" rowspan="1">Nested–proximal</td>
<td align="right" colspan="1" rowspan="1">Typical<break></break></td>
<td align="right" colspan="1" rowspan="1">Typical<break></break></td>
<td align="right" colspan="1" rowspan="1">Typical<break></break></td>
<td align="right" colspan="1" rowspan="1">Typical</td>
<td align="right" colspan="1" rowspan="1">Typical</td>
<td align="right" colspan="1" rowspan="1">Typical</td>
<td align="right" colspan="1" rowspan="1">Typical</td>
<td align="right" colspan="1" rowspan="1">Typical</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>De novo</italic> 22q11.2 deletion</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
<td align="right" colspan="1" rowspan="1">Yes</td>
<td align="right" colspan="1" rowspan="1">Probable</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>Abbreviations: 22q11.2DS, 22q11.2 deletion syndrome; LBs, Lewy bodies; NPD, No Parkinson’s disease; PD, Parkinson’s disease; VPI, velopharyngeal insufficiency; y, year</p>
</fn>
<fn id="t001fn002">
<p><sup>a</sup>Detailed phenotypic reports published previously for PD1-PD3 [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>] and NPD4 [<xref ref-type="bibr" rid="pone.0173944.ref010">10</xref>]</p>
</fn>
<fn id="t001fn003">
<p><sup>b</sup>Tetralogy of Fallot (PD2); ventricular septal defect (NPD1); ventricular septal defect and atrial septal defect (NPD4, NPD6)</p>
</fn>
<fn id="t001fn004">
<p><sup>c</sup>Lifetime history; Other psychiatric disorders were obsessive compulsive disorder (NPD1), generalized anxiety disorder (NPD5, NPD6)</p>
</fn>
<fn id="t001fn005">
<p><sup>d</sup>Lifetime history; Note all subjects had a lifetime history of hypocalcemia</p>
</fn>
<fn id="t001fn006">
<p><sup>e</sup>Age at molecular diagnosis of 22q11.2 deletion was 44, 52, 53 years for subjects with Parkinson’s disease and 4, 21, 27, 39, 41, 42 years for subjects without Parkinson’s disease</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Informed consent was obtained in writing and the study was approved by research ethics boards at the Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</p>
</sec>
<sec id="sec008">
<title>Whole-genome sequencing</title>
<p>The overall WGS approach was based on methods used in recent studies of schizophrenia [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>] and autism [<xref ref-type="bibr" rid="pone.0173944.ref009">9</xref>]. Detailed laboratory and bioinformatics methods are described elsewhere [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>]. In brief, genomic DNA was extracted from whole blood and sequenced using the Complete Genomics platform (pipeline and assembly version 2.2). On average, 99.0% of the genome was covered with at least 5x sequence depth relative to the NCBI build 37 human genome reference sequence. Of the exome, 94.4% and 72.3% was covered with at least 20x and 40x sequence depth, respectively. Only high-quality variants, defined as those with Complete Genomics “highquality” variant call scores and that also met stringent in-house quality criteria [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0173944.ref009">9</xref>] were included. The effects (e.g., nonsense, missense, or frameshift mutations) and classifications (e.g., in exonic, intronic, or intergenic regions) of variants across the genome were annotated using ANNOVAR (November 2014) software [<xref ref-type="bibr" rid="pone.0173944.ref011">11</xref>]. Rarity was annotated using the three major publicly-available reference datasets based on WGS and whole exome sequencing, i.e., 1000 Genomes [<xref ref-type="bibr" rid="pone.0173944.ref012">12</xref>], NHLBI-Exome Sequencing Project [<xref ref-type="bibr" rid="pone.0173944.ref013">13</xref>] and Exome Aggregation Consortium [<xref ref-type="bibr" rid="pone.0173944.ref014">14</xref>], and two in-house platform-matched whole-genome reference data-sets. We defined rare variants using a standard rarity threshold of those not exceeding the 1% alternate allele frequency threshold (minor allele frequency [MAF]&lt;0.01) in all datasets, including specific ethnic subgroups.</p>
</sec>
<sec id="sec009">
<title>Non-synonymous and structural variants</title>
<p>We examined rare single-nucleotide sequence variants (SNVs) and in/dels affecting coding genes that included loss-of-function (stop-gain/nonsense, frameshift, and core splice site alterations) and missense mutations categorized as deleterious using standard variant impact predictor tools and genomic conservation indexes, as reported previously [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0173944.ref009">9</xref>]. Missense variants were predicted damaging (deleterious) when they met at least four of seven criteria: high conservation by PhyloP placental mammal (≥2.3) and PhyloP 100vertebrate (≥4) [<xref ref-type="bibr" rid="pone.0173944.ref015">15</xref>] and predicted damaging by SIFT ≤0.05 [<xref ref-type="bibr" rid="pone.0173944.ref016">16</xref>], PolyPhen2 ≥0.90 [<xref ref-type="bibr" rid="pone.0173944.ref017">17</xref>], Mutation Assessor ≥1.9 [<xref ref-type="bibr" rid="pone.0173944.ref018">18</xref>], CADD Phred score ≥15 [<xref ref-type="bibr" rid="pone.0173944.ref019">19</xref>], and MutationTaster score &gt;0.5 [<xref ref-type="bibr" rid="pone.0173944.ref020">20</xref>]. We restricted the analyses to diploid regions of the genome with the exception of the 22q11.2 deletion to help manage the risk of false positives.</p>
<p>Copy number variant and other structural variants detected by Complete Genomics pipeline and assembly version 2.2 were annotated and filtered as described elsewhere [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0173944.ref009">9</xref>]. We considered only high-quality rare variants that overlapped a coding gene exon of a RefSeq gene [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0173944.ref009">9</xref>]. 22q11.2 deletions were confirmed in all patients (<xref ref-type="table" rid="pone.0173944.t001">Table 1</xref>).</p>
</sec>
<sec id="sec010">
<title>Gene-set analyses</title>
<p>The analysis was restricted to a candidate gene approach of rare variants involving coding regions of the genome. Rare coding sequence variants are enriched for those that are deleterious and have a moderate to large effect on disease risk. We have previously shown that this approach, even for the small sample selected for our pilot WGS study of 22q11.2DS, can yield substantial effect sizes for a neuropsychiatric phenotype [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>]. Three hypothesis-driven gene-sets were selected <italic>a priori</italic> for testing based on proposed possible PD mechanisms in 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref021">21</xref>]: (1) 22q11.2 deletion region genes (n = 46) [<xref ref-type="bibr" rid="pone.0173944.ref022">22</xref>]; (2) known causative and PD risk candidate genes (n = 43); and (3) genes identified as functionally-relevant to PD (n = 1000) based on physical protein interactions and co-expression with known PD gene candidates, excluding the 22q11.2 region and the known causative and risk PD genes that were examined as separate gene-sets.</p>
<p>The known candidate PD gene-set (<xref ref-type="supplementary-material" rid="pone.0173944.s002">S1 Table</xref>) included genes described in the scientific literature and/or, OMIM entries for Parkinson’s disease (#168600), and from the PDgene database of genome-wide association study common variant findings (<ext-link ext-link-type="uri" xlink:href="http://www.pdgene.org/">www.pdgene.org</ext-link>; accessed October 2015) [<xref ref-type="bibr" rid="pone.0173944.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0173944.ref024">24</xref>]. We used this approach [<xref ref-type="bibr" rid="pone.0173944.ref025">25</xref>] because rare and common variants can involve the same PD risk gene (e.g., <italic>SNCA</italic>) [<xref ref-type="bibr" rid="pone.0173944.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0173944.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0173944.ref024">24</xref>]. We opted to assess all genes (e.g., confirmed, unconfirmed, and rarely) reported to be involved in Parkinson’s disease in order to limit the possibility of a false negative with respect to susceptibility to Parkinson’s disease in patients with 22q11.2DS.</p>
<p>The gene-set of 1000 “PD-relevant” genes was generated using the genome-wide candidate gene prioritization tool, Endeavour [<xref ref-type="bibr" rid="pone.0173944.ref026">26</xref>]. Endeavour prioritizes genes by assessing how similar they are to genes already known to be involved in the process of interest [<xref ref-type="bibr" rid="pone.0173944.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0173944.ref028">28</xref>]. To generate a genome-wide ranked list of candidate “PD-relevant” genes, the 43 genes comprising the known PD gene-set (<xref ref-type="supplementary-material" rid="pone.0173944.s002">S1 Table</xref>) were used as input training genes with data imported from standard annotation databases (Gene Ontology, Kegg, SwissProt), protein-protein interaction databases (BIND, BioGRID, Hprd, InNetDb, Intact, Mint), and a human gene expression database [<xref ref-type="bibr" rid="pone.0173944.ref029">29</xref>]. This yielded 1561 ranked genes mapped to current unique HGNC gene symbols (<xref ref-type="supplementary-material" rid="pone.0173944.s003">S2 Table</xref>). We <italic>a priori</italic> restricted the PD-relevant gene-set to the highest-ranked 1000 genes (“top 1000 genes”; <xref ref-type="supplementary-material" rid="pone.0173944.s003">S2 Table</xref>) to help prevent the inclusion of genes with weak evidence for involvement in PD-related function, while including a sufficient number of genes to perform a proof-of-principle genome-wide burden analysis [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>]. As a negative control, we generated 10 000 random gene-sets composed of 1000 “non-PD relevant” genes each from a set of 14 489 genes that met the following criteria: (1) at least one Gene Ontology [<xref ref-type="bibr" rid="pone.0173944.ref030">30</xref>] annotation with ≤ 500 genes, to ensure that the genes were annotated with a functional term that was sufficiently specific, and (2) were not in the known candidate PD gene-set or the PD-relevant gene-set (top 1000).</p>
</sec>
<sec id="sec011">
<title>Common variant polygenic risk score</title>
<p>We calculated the polygenic score using the approach previously described for 22q11.2DS-associated schizophrenia [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>] and the International Schizophrenia Consortium [<xref ref-type="bibr" rid="pone.0173944.ref031">31</xref>]. Our analysis was restricted to the top 10 000 most significant SNPs with original nominal association <italic>p</italic>-values and odds-ratios that are publicly available from PDgene [<xref ref-type="bibr" rid="pone.0173944.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0173944.ref024">24</xref>]. Of these, 3534 SNPs were mapped to variants passing quality filters in all nine genomes assessed in this study. Allele counts were computed as the number of alleles that matched to the allele used for association analysis. The SNP-wise risk score was calculated as the product of the allele count and the log (odds-ratio). The polygenic risk score [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>] for each 22q11.2DS subject was calculated as the sum of all respective SNP-wise risk scores using nominal association <italic>p</italic>-value thresholds ≤1e<sup>-3</sup> and ≤1e<sup>-5</sup>, as well as one more stringent (≤1e<sup>-7</sup>) corresponding to 3410, 1315, and 388 SNPs each.</p>
</sec>
<sec id="sec012">
<title>Statistical analyses</title>
<p>We used one-sided independent <italic>t-</italic>tests in these exploratory analyses to assess rare variant burden count and common variant polygenic risk score between groups, performed with SAS version 9.4 software. Statistical significance was defined using nominal uncorrected <italic>p</italic>&lt;0.05. The false discovery rate (FDR) was calculated using the Benjamini-Hochberg procedure.</p>
</sec>
</sec>
<sec id="sec013" sec-type="results">
<title>Results</title>
<p><xref ref-type="table" rid="pone.0173944.t001">Table 1</xref> summarizes the demographic, clinical, and 22q11.2 deletion data for the subjects studied. No feature of 22q11.2DS, apart from the presence of neuropathologically-confirmed PD, was unique to the 22q11.2DS-PD cases. The clinical heterogeneity among the subjects was typical for 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref032">32</xref>–<xref ref-type="bibr" rid="pone.0173944.ref034">34</xref>]. Expression of schizophrenia was similarly common (66.6%) in both groups. Among the subjects with PD, there was a history of borderline intellectual disability and an isolated seizure in one subject and a congenital heart defect in another. Major co-morbid conditions among the patients without PD included intellectual disability (n = 2 mild; n = 4 borderline), seizures (n = 3 recurrent; n = 1 single), congenital heart defects (n = 3), and other psychiatric disorders including obsessive compulsive disorder (n = 1) and generalized anxiety disorder (n = 2). Patients in the PD group were diagnosed with 22q11.2DS at an older mean age (49.6±4.9 years) than those without PD (29±14.9 years, <italic>p</italic> = 0.048). One subject with PD had a 1.4 Mb nested proximal 22q11.2 deletion (<xref ref-type="supplementary-material" rid="pone.0173944.s004">S3 Table</xref>). The deletion breakpoints were consistent with typical deletions in the other eight subjects (n = 7, 2.6 Mb deletion including two with PD; n = 1, 2.9 Mb deletion; <xref ref-type="supplementary-material" rid="pone.0173944.s004">S3 Table</xref>). There were no deleterious nonsynonymous variants near the 22q11.2 deletion breakpoints (i.e., within 4 Mb).</p>
<p>WGS results for the 22q11.2 deletion region revealed only a single rare missense variant involving different brain-expressed genes in each of three subjects (<xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>). None involved a putative 22q11.2 region PD candidate gene [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref021">21</xref>] and the variants in cases PD1 and PD3 involved genes <italic>TRMT2A</italic> and <italic>DGCR2</italic>, encoding proteins of largely unknown function (<xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>) [<xref ref-type="bibr" rid="pone.0173944.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0173944.ref036">36</xref>].</p>
<table-wrap id="pone.0173944.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173944.t002</object-id>
<label>Table 2</label>
<caption>
<title>Rare nonsynonymous variants in 22q11.2 deletion-associated early-onset Parkinson’s disease (22q11.2ds-pd) patients compared with 22q11.2 deletion patients with no Parkinson’s disease (22q11.2DS-NPD).</title>
</caption>
<alternatives>
<graphic id="pone.0173944.t002g" xlink:href="pone.0173944.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2"></th>
<th align="center" colspan="12" rowspan="1">Rare deleterious coding variant counts<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></th>
</tr>
<tr>
<th align="center" colspan="3" rowspan="1">22q11.2DS-PD</th>
<th align="center" colspan="6" rowspan="1">22q11.2DS-NPD</th>
<th align="center" colspan="3" rowspan="1">Analyses</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Subject Identifier</th>
<th align="center" colspan="1" rowspan="1">PD1</th>
<th align="center" colspan="1" rowspan="1">PD2</th>
<th align="center" colspan="1" rowspan="1">PD3</th>
<th align="center" colspan="1" rowspan="1">NPD1</th>
<th align="center" colspan="1" rowspan="1">NPD2</th>
<th align="center" colspan="1" rowspan="1">NPD3</th>
<th align="center" colspan="1" rowspan="1">NPD4</th>
<th align="center" colspan="1" rowspan="1">NPD5</th>
<th align="center" colspan="1" rowspan="1">NPD6</th>
<th align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">PD Mean (SD)</th>
<th align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">NPD Mean (SD)</th>
<th align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">
<italic>p</italic>
<xref ref-type="table-fn" rid="t002fn002">
<sup>
<italic>b</italic>
</sup>
</xref>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Genome-wide total</bold>
</td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Loss-of-function variants</td>
<td align="right" colspan="1" rowspan="1">9</td>
<td align="right" colspan="1" rowspan="1">7</td>
<td align="right" colspan="1" rowspan="1">14</td>
<td align="right" colspan="1" rowspan="1">22</td>
<td align="right" colspan="1" rowspan="1">17</td>
<td align="right" colspan="1" rowspan="1">22</td>
<td align="right" colspan="1" rowspan="1">13</td>
<td align="right" colspan="1" rowspan="1">9</td>
<td align="right" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">10.0 (3.6)</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">15.7 (5.6)</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Missense variants</td>
<td align="right" colspan="1" rowspan="1">97</td>
<td align="right" colspan="1" rowspan="1">98</td>
<td align="right" colspan="1" rowspan="1">117</td>
<td align="right" colspan="1" rowspan="1">102</td>
<td align="right" colspan="1" rowspan="1">79</td>
<td align="right" colspan="1" rowspan="1">95</td>
<td align="right" colspan="1" rowspan="1">90</td>
<td align="right" colspan="1" rowspan="1">82</td>
<td align="right" colspan="1" rowspan="1">89</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">104.0 (11.3)</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">89.5 (8.4)</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Candidate gene-sets for 22q11.2DS-PD</bold>
</td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="right" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">22q11.2 deletion region genes (46 genes)</td>
<td align="right" colspan="1" rowspan="1">1<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">1<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">1<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.7 (0.6)</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.2 (0.4)</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Known PD candidate genes (43 genes<xref ref-type="table-fn" rid="t002fn004"><sup>d</sup></xref>)</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0<xref ref-type="table-fn" rid="t002fn005"><sup>e</sup></xref></td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">-</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">-</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">-</td>
</tr>
<tr>
<td align="left" colspan="13" rowspan="1">PD-relevant genes (top 1000 candidate genes<xref ref-type="table-fn" rid="t002fn006"><sup>f</sup></xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Loss-of-function variants</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.7 (0.6)</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">1.7 (1.1)</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">0.29</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Missense variants</td>
<td align="right" colspan="1" rowspan="1">12</td>
<td align="right" colspan="1" rowspan="1">7</td>
<td align="right" colspan="1" rowspan="1">11</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">4</td>
<td align="right" colspan="1" rowspan="1">4</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="right" colspan="1" rowspan="1">8</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#FFFFFF">10.0 (2.6)</td>
<td align="right" colspan="1" rowspan="1" style="background-color:#FFFFFF">4.8 (1.7)</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">
<bold>0.03</bold>
</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p><sup>a</sup>Rare (MAF&lt;0.01) autosomal heterozygous deleterious variant counts. Only one homozygous variant was identified (missense variant in <italic>ZNF418</italic>, no apparent functional relevance to PD, in PD3)</p>
</fn>
<fn id="t002fn002">
<p><sup>b</sup>Nominal <italic>p</italic> value for one-sided independent <italic>t</italic>-test. Non-parametric Wilcoxon testing yielded the same pattern of results</p>
</fn>
<fn id="t002fn003">
<p><sup>c</sup>Missense variants in three brain-expressed genes in the proximal typical deletion region, none of which are considered 22q11.2 PD candidate genes [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]: <italic>TRMT2A</italic>, tRNA methyltransferase 2 homolog A [<italic>S</italic>. <italic>cerevisiae</italic>] (PD1); <italic>DGCR2</italic>, DiGeorge syndrome critical region 2 (PD3); <italic>GNB1L</italic>, guanine nucleotide binding protein [G protein], beta-polypeptide 1-like (NPD6)</p>
</fn>
<fn id="t002fn004">
<p><sup>d</sup>PD candidate causative and risk genes (<xref ref-type="supplementary-material" rid="pone.0173944.s002">S1 Table</xref>)</p>
</fn>
<fn id="t002fn005">
<p><sup>e</sup>A false positive missense variant in <italic>PARK2</italic> (subject PD3) was not confirmed: Sanger sequencing showed no mutation [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>].</p>
</fn>
<fn id="t002fn006">
<p><sup>f</sup>Top 1000 genome-wide genes ranked as potential PD-relevant genes using the genome-wide candidate gene prioritization tool, Endeavour</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>With respect to the gene-set of 43 putative candidate PD genes (<xref ref-type="supplementary-material" rid="pone.0173944.s002">S1 Table</xref>), no deleterious nonsynonymous variants (<xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>), or copy number or other structural variants, were identified in any of the nine subjects.</p>
<p>Overall the genome-wide burden of rare deleterious missense variants in coding sequence genes was non-significantly greater in the PD cases than in the patients without PD (<xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>). We assessed a candidate gene-set functionally restricted to the top 1000 genome-wide ranked PD-relevant genes, excluding those in the 22q11.2 deletion region or in known PD genes. This revealed a greater burden of rare deleterious missense variants in the 22q11.2DS-PD cases (nominal <italic>p</italic> = 0.03; FDR = 10%; <xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>). The result remained significant (<italic>p</italic> = 0.04) after correcting for the total number of rare deleterious missense variants per subject. To test the specificity of these findings, we assessed between-group differences for burden of rare deleterious missense variants in 10 000 random non-PD relevant gene-sets. We found that &lt;5% of the resulting <italic>p</italic>-values were less than the <italic>p</italic>-value yielded from the top 1000 genome-wide ranked PD-relevant genes (<italic>p</italic> = 0.03), suggesting the results were specific to the PD-relevant gene-set. Results for the few loss-of-function variants were non-significant (<xref ref-type="table" rid="pone.0173944.t002">Table 2</xref>). There were no genome-wide PD-relevant copy number or other structural variants identified [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>].</p>
<p>Secondary analyses showed that the genes with these rare missense variants ranked significantly higher in the PD-relevant gene-set in the PD patients (mean rank, 196) than those in the cases without PD (mean rank, 316; <italic>p</italic> = 0.009), and that burden results remained significant using a higher stringency threshold (top 500 ranked candidates in the PD network gene-set, <xref ref-type="supplementary-material" rid="pone.0173944.s003">S2 Table</xref>; 22q11.2DS-PD mean = 5.7, SD = 2.1 vs. 22q11.2DS-NPD mean = 2.0, SD = 1.7; <italic>p</italic> = 0.03).</p>
<p>Also, a negative control analysis using lifetime history of schizophrenia or seizure(s) in place of PD as the phenotype of interest [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>] showed no significant differences in PD network missense variant burden between groups at either stringency threshold (schizophrenia: top 1000 ranked PD-relevant genes, <italic>p</italic> = 0.81; top 500 genes, <italic>p</italic> = 0.54; seizure(s): top 1000 ranked PD-relevant genes, <italic>p</italic> = 0.17; top 500 genes, <italic>p</italic> = 0.77).</p>
<p><xref ref-type="table" rid="pone.0173944.t003">Table 3</xref> shows the PD-relevant genes with rare nonsynonymous variants in the subjects with PD. These included <italic>KLF11</italic>, a regulator of monoamine oxidase B expression [<xref ref-type="bibr" rid="pone.0173944.ref037">37</xref>], and <italic>MAP2</italic>, a neuronal cytoskeletal protein found in Lewy bodies in PD patients (<xref ref-type="table" rid="pone.0173944.t003">Table 3</xref>) [<xref ref-type="bibr" rid="pone.0173944.ref038">38</xref>]. There were two genes with variants that affected more than one case with PD (<xref ref-type="table" rid="pone.0173944.t003">Table 3</xref>). The same rare variant (MAF≤0.01) in <italic>LARS2</italic> (rs116826217) was identified in subjects PD2 and PD3. This gene encodes a mitochondrial aminoacyl-tRNA synthetase reported to be significantly down-regulated (~1.45 fold) in substantia nigra dopaminergic neurons of patients with idiopathic PD [<xref ref-type="bibr" rid="pone.0173944.ref039">39</xref>]. Two different rare variants in <italic>TTN</italic> were identified in subjects PD1 and PD3. Although ranked in the top 100 candidates in the PD-relevant gene-set, <italic>TTN</italic> is highly polymorphic and one of the largest genes in the genome, thus caution is warranted in the interpretation of the potential pathogenicity of variants [<xref ref-type="bibr" rid="pone.0173944.ref040">40</xref>].</p>
<table-wrap id="pone.0173944.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173944.t003</object-id>
<label>Table 3</label>
<caption>
<title>Rare nonsynonymous variants in autosomal genes in a genome-wide Parkinson’s Disease-relevant gene-set in three unrelated patients with 22q11.2 deletion-associated Parkinson’s disease.</title>
</caption>
<alternatives>
<graphic id="pone.0173944.t003g" xlink:href="pone.0173944.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2">Case</th>
<th align="center" colspan="1" rowspan="2">Gene symbol</th>
<th align="center" colspan="1" rowspan="2">Gene Name</th>
<th align="center" colspan="1" rowspan="2">Variant type</th>
<th align="center" colspan="1" rowspan="2">Rank<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></th>
<th align="center" colspan="2" rowspan="1">Coordinates (GRCh37)</th>
<th align="center" colspan="1" rowspan="2">Ref. allele</th>
<th align="center" colspan="1" rowspan="2">Alt. allele</th>
<th align="center" colspan="1" rowspan="2">Entrez ID</th>
<th align="center" colspan="1" rowspan="2">OMIM ID</th>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>Chr.</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>Position</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="13">
<bold>PD1</bold>
</td>
<td align="left" colspan="1" rowspan="1">TTN<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
<td align="left" colspan="1" rowspan="1">titin</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">57</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">179560789</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="right" colspan="1" rowspan="1">7273</td>
<td align="right" colspan="1" rowspan="1">188840</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MAP2</td>
<td align="left" colspan="1" rowspan="1">microtubule-associated protein 2</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">147</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">210543361</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">4133</td>
<td align="right" colspan="1" rowspan="1">157130</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HAL</td>
<td align="left" colspan="1" rowspan="1">histidine ammonia-lyase</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">180</td>
<td align="right" colspan="1" rowspan="1">12</td>
<td align="right" colspan="1" rowspan="1">96371731</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">3034</td>
<td align="right" colspan="1" rowspan="1">609457</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GPATCH8</td>
<td align="left" colspan="1" rowspan="1">G patch domain containing 8</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">184</td>
<td align="right" colspan="1" rowspan="1">17</td>
<td align="right" colspan="1" rowspan="1">42476786</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">23131</td>
<td align="right" colspan="1" rowspan="1">614396</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DOCK4</td>
<td align="left" colspan="1" rowspan="1">dedicator of cytokinesis 4</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">213</td>
<td align="right" colspan="1" rowspan="1">7</td>
<td align="right" colspan="1" rowspan="1">111368481</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">9732</td>
<td align="right" colspan="1" rowspan="1">607679</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MYH9</td>
<td align="left" colspan="1" rowspan="1">myosin, heavy chain 9, non-muscle</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">229</td>
<td align="right" colspan="1" rowspan="1">22</td>
<td align="right" colspan="1" rowspan="1">36681790</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">4627</td>
<td align="right" colspan="1" rowspan="1">160775</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KHK</td>
<td align="left" colspan="1" rowspan="1">ketohexokinase (fructokinase)</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">256</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">27320515</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">3795</td>
<td align="right" colspan="1" rowspan="1">614058</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HSD17B4</td>
<td align="left" colspan="1" rowspan="1">hydroxysteroid (17-beta) dehydrogenase 4</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">265</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="right" colspan="1" rowspan="1">118844919</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">3295</td>
<td align="right" colspan="1" rowspan="1">601860</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EYA1</td>
<td align="left" colspan="1" rowspan="1">EYA transcriptional coactivator and phosphatase 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">648</td>
<td align="right" colspan="1" rowspan="1">8</td>
<td align="right" colspan="1" rowspan="1">72246370</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">2138</td>
<td align="right" colspan="1" rowspan="1">601653</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ATXN7</td>
<td align="left" colspan="1" rowspan="1">ataxin 7</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">735</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">63968025</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">6314</td>
<td align="right" colspan="1" rowspan="1">607640</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RNF123</td>
<td align="left" colspan="1" rowspan="1">ring finger protein 123</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">804</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">49737107</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">63891</td>
<td align="right" colspan="1" rowspan="1">614472</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G3BP1</td>
<td align="left" colspan="1" rowspan="1">GTPase activating protein (SH3 domain) binding protein 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">997</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="right" colspan="1" rowspan="1">151176801</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="right" colspan="1" rowspan="1">10146</td>
<td align="right" colspan="1" rowspan="1">608431</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PDE1A</td>
<td align="left" colspan="1" rowspan="1">Phosphodiesterase 1A, calmodulin-dependent</td>
<td align="left" colspan="1" rowspan="1">LOF (deletion)</td>
<td align="right" colspan="1" rowspan="1">177</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">183106620 to 183106623</td>
<td align="left" colspan="1" rowspan="1">GTTT</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="right" colspan="1" rowspan="1">5136</td>
<td align="right" colspan="1" rowspan="1">171890</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="8">
<bold>PD2</bold>
</td>
<td align="left" colspan="1" rowspan="1">KLF11</td>
<td align="left" colspan="1" rowspan="1">Kruppel-like factor 11</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">75</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">10188597</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">8462</td>
<td align="right" colspan="1" rowspan="1">188840</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GCA</td>
<td align="left" colspan="1" rowspan="1">grancalcin, EF-hand calcium binding protein</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">86</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">163208877</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">25801</td>
<td align="right" colspan="1" rowspan="1">176878</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTPRG</td>
<td align="left" colspan="1" rowspan="1">protein tyrosine phosphatase, receptor type, G</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">165</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">62189076</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">5793</td>
<td align="right" colspan="1" rowspan="1">172250</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ADCY6</td>
<td align="left" colspan="1" rowspan="1">adenylate cyclase 6</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">408</td>
<td align="right" colspan="1" rowspan="1">12</td>
<td align="right" colspan="1" rowspan="1">49165650</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">112</td>
<td align="right" colspan="1" rowspan="1">603301</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NFATC1</td>
<td align="left" colspan="1" rowspan="1">nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">887</td>
<td align="right" colspan="1" rowspan="1">18</td>
<td align="right" colspan="1" rowspan="1">77171480</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="right" colspan="1" rowspan="1">4772</td>
<td align="right" colspan="1" rowspan="1">600489</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LARS2<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
<td align="left" colspan="1" rowspan="1">leucyl-tRNA synthetase 2, mitochondrial</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">921</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">45537795</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">23395</td>
<td align="right" colspan="1" rowspan="1">604544</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TYR</td>
<td align="left" colspan="1" rowspan="1">tyrosinase</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">970</td>
<td align="right" colspan="1" rowspan="1">11</td>
<td align="right" colspan="1" rowspan="1">89017973</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">7299</td>
<td align="right" colspan="1" rowspan="1">606933</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C19orf80</td>
<td align="left" colspan="1" rowspan="1">chromosome 19 open reading frame 80</td>
<td align="left" colspan="1" rowspan="1">LOF (nonsense)</td>
<td align="right" colspan="1" rowspan="1">936</td>
<td align="right" colspan="1" rowspan="1">19</td>
<td align="right" colspan="1" rowspan="1">11350874</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">55908</td>
<td align="right" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="11">
<bold>PD3</bold>
</td>
<td align="left" colspan="1" rowspan="1">ANKHD1</td>
<td align="left" colspan="1" rowspan="1">ankyrin repeat and KH domain containing 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">22</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="right" colspan="1" rowspan="1">139815809</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="right" colspan="1" rowspan="1">54882</td>
<td align="right" colspan="1" rowspan="1">610500</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ARG1</td>
<td align="left" colspan="1" rowspan="1">arginase 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">29</td>
<td align="right" colspan="1" rowspan="1">6</td>
<td align="right" colspan="1" rowspan="1">131904553</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">383</td>
<td align="right" colspan="1" rowspan="1">608313</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TTN<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
<td align="left" colspan="1" rowspan="1">titin</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">57</td>
<td align="right" colspan="1" rowspan="1">2</td>
<td align="right" colspan="1" rowspan="1">179430433</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">7273</td>
<td align="right" colspan="1" rowspan="1">188840</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MTMR14</td>
<td align="left" colspan="1" rowspan="1">myotubularin related protein 14</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">469</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">9714418</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="right" colspan="1" rowspan="1">64419</td>
<td align="right" colspan="1" rowspan="1">611089</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MC5R</td>
<td align="left" colspan="1" rowspan="1">melanocortin 5 receptor</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">489</td>
<td align="right" colspan="1" rowspan="1">18</td>
<td align="right" colspan="1" rowspan="1">13826678</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">4161</td>
<td align="right" colspan="1" rowspan="1">600042</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DHTKD1</td>
<td align="left" colspan="1" rowspan="1">dehydrogenase E1 and transketolase domain containing 1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">502</td>
<td align="right" colspan="1" rowspan="1">10</td>
<td align="right" colspan="1" rowspan="1">12129639</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">55526</td>
<td align="right" colspan="1" rowspan="1">614984</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ALDH4A1</td>
<td align="left" colspan="1" rowspan="1">aldehyde dehydrogenase 4 family, member A1</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">512</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">19209862</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="right" colspan="1" rowspan="1">8659</td>
<td align="right" colspan="1" rowspan="1">606811</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SMG6</td>
<td align="left" colspan="1" rowspan="1">SMG6 nonsense mediated mRNA decay factor</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">585</td>
<td align="right" colspan="1" rowspan="1">17</td>
<td align="right" colspan="1" rowspan="1">2202573</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">23293</td>
<td align="right" colspan="1" rowspan="1">610963</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HARS</td>
<td align="left" colspan="1" rowspan="1">histidyl-tRNA synthetase</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">815</td>
<td align="right" colspan="1" rowspan="1">5</td>
<td align="right" colspan="1" rowspan="1">140070517</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">3035</td>
<td align="right" colspan="1" rowspan="1">142810</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LARS2<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
<td align="left" colspan="1" rowspan="1">leucyl-tRNA synthetase 2, mitochondrial</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">921</td>
<td align="right" colspan="1" rowspan="1">3</td>
<td align="right" colspan="1" rowspan="1">45537795</td>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="right" colspan="1" rowspan="1">23395</td>
<td align="right" colspan="1" rowspan="1">604544</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PGLYRP4</td>
<td align="left" colspan="1" rowspan="1">peptidoglycan recognition protein 4</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="right" colspan="1" rowspan="1">972</td>
<td align="right" colspan="1" rowspan="1">1</td>
<td align="right" colspan="1" rowspan="1">153303392</td>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">T</td>
<td align="right" colspan="1" rowspan="1">57115</td>
<td align="right" colspan="1" rowspan="1">608198</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>Abbreviations: Alt. allele, alternate allele; Chr., chromosome; LOF, loss-of-function; NA, not applicable; Ref. allele, reference allele</p>
</fn>
<fn id="t003fn002">
<p><sup>a</sup>Genome-wide rank as a potential PD-relevant gene using the genome-wide candidate gene prioritization tool, Endeavour</p>
</fn>
<fn id="t003fn003">
<p><sup>b</sup>Variants involving the same gene in two patients with 22q11.2DS-associated Parkinson’s disease (same variant with respect to <italic>LARS2</italic>)</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>At the most stringent nominal <italic>p</italic>-value threshold of ≤1e<sup>-7</sup> (corresponding to just 388 SNPs), the mean polygenic risk score was non-significantly greater in the PD cases (-18.6 vs. -23.7; <italic>p</italic> = 0.17; <xref ref-type="supplementary-material" rid="pone.0173944.s001">S1 Fig</xref>). A similar non-significant trend with more modest relative differences was observed at more lenient SNP nominal p-value thresholds.</p>
</sec>
<sec id="sec014" sec-type="conclusions">
<title>Discussion</title>
<p>This first ever study using WGS in PD provides initial proof-of-principle of the utility of next-generation sequencing for studying the etiology of PD, and the potential advantage of using a genetic model, here, 22q11.2DS. The results provide preliminary evidence that genome-wide burden of rare deleterious variants in genes functionally relevant to PD may collectively act to increase the likelihood of expression of PD in the presence of a 22q11.2 deletion. This is consistent with, and extends to PD, findings using this WGS approach for schizophrenia in 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref004">4</xref>]. These findings will require confirmation in adequately powered larger samples.</p>
<p>The results of this proof-of-principle study suggest that hemizygosity of the 22q11.2 deletion region, together with each individual’s cumulative genome-wide burden of rare deleterious variants in PD-relevant pathways, with perhaps some modification related to cumulative common variants, may form a “multi-hit” pathway to the expression of PD in 22q11.2DS. Collectively, the findings provide an initial glimpse of the potential for WGS to reveal a more complete view of the complex genetic architecture of PD at the individual level that could potentially be generalizable to other forms of PD. Reduced gene dosage in the 22q11.2 region appears to be a more plausible mechanism for increasing risk of early-onset PD in 22q11.2DS than does the unmasking of a recessive allele on the intact 22q11.2 chromosome.</p>
<p>With this sample size, we could not find evidence of a contribution to risk from pathogenic mutations in well-known or other risk genes for PD, nor loss-of-function mutations affecting genes in the broader PD-relevant network. Notably, enrichment of additional rare <italic>ATP13A2</italic> variants was recently reported in <italic>LRRK2-</italic>associated PD [<xref ref-type="bibr" rid="pone.0173944.ref041">41</xref>]. Larger studies of patients with 22q11.2DS-associated PD will help clarify if additional rare variants in known PD genes could impact penetrance of PD in this genetic population. Though non-significant, the finding of a less negative polygenic score in the 22q11.2DS-PD cases suggests the possibility that 22q11.2DS patients who develop PD may have fewer protective PD risk alleles. These preliminary findings provide hypotheses that await testing in larger, well-powered samples that will become feasible as more patients with 22q11.2DS-PD continue to be identified [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0173944.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0173944.ref049">49</xref>].</p>
<p>The smaller proximal deletion that occurs in about 10% of cases [<xref ref-type="bibr" rid="pone.0173944.ref050">50</xref>, <xref ref-type="bibr" rid="pone.0173944.ref051">51</xref>] was identified in one of the 22q11.2DS patients with PD sequenced in this study [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>]. Adequately-powered studies will be needed to investigate the molecular nature of the deletion and the potential impact of neighbouring mutations as a possible source of discordance for PD in 22q11.2DS. Notably, there appears to be no relationship between deletion length and expression of other major neuropsychiatric features in 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref052">52</xref>–<xref ref-type="bibr" rid="pone.0173944.ref054">54</xref>]. We found no evidence that nonsynonymous variants near the 22q11.2 deletion breakpoints impacted expression of PD.</p>
<p>The results of this study appear to be consistent with the polygenic genetic architecture expected for a common, complex neurological disorder such as PD. Studies using a comparable design in this and other genetic models of PD (e.g., <italic>LRRK2</italic>-associated PD) could help to reveal generalizable mechanisms relevant to the reduced penetrance associated with most mutations. Non-genetic factors may also be important to include in future designs. For example, Vitamin D deficiency may increase PD risk [<xref ref-type="bibr" rid="pone.0173944.ref055">55</xref>], and is a common finding in 22q11.2DS related to inadequate levels of parathyroid hormone secretion [<xref ref-type="bibr" rid="pone.0173944.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0173944.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0173944.ref056">56</xref>]. Prospective studies could help clarify if Vitamin D levels may be involved in mediating PD risk in 22q11.2DS.</p>
<p>The small sample size necessitated analyses focused on a targeted candidate gene-set approach. This included reliance on reported PD-associated genes to seed a network to prioritize rare variants across the genome. More individual PD genes are likely to be discovered, and others may be dropped from such lists as data accrue. Although this initial study produced a nominally significant enrichment of rare putatively damaging missense variants in PD-relevant genes among the PD cases, there was no correction for multiple comparisons. We limited the number of tests to the minimum by considering only gene-sets with relevance to PD. These findings will require replication in adequately powered samples. We were underpowered in this preliminary study to include clinical covariates, including other neuropsychiatric phenotypes, in our analyses. The clinical phenotype of 22q11.2DS patients with PD reported to date appears consistent with the variable expression and reduced penetrance of the associated features that is characteristic of 22q11.2DS [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0173944.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0173944.ref049">49</xref>]. However, there were no significant differences in the PD network variant burden using other major neurological phenotypes (e.g., expression of schizophrenia or seizures) as the grouping variable, suggesting the findings may be specific to PD-relevant genes.</p>
<p>Advances in WGS bioinformatics methods will permit informative analyses of non-coding regions in future studies. The 22q11.2 region includes <italic>DGCR8</italic>, a key gene in the biogenesis of brain microRNAs, in addition to seven microRNAs [<xref ref-type="bibr" rid="pone.0173944.ref057">57</xref>]. It remains possible that one or more of the cases without PD may go on to develop PD at a later age, limiting the power to determine between-group differences. Evaluating clinical and neuroimaging phenotypes in genetic studies of patients with 22q11.2DS without a diagnosis of PD may help clarify disease risk. We recently found that adults with 22q11.2DS without a diagnosis of PD exhibit olfactory and motor deficits compared with age-matched healthy controls [<xref ref-type="bibr" rid="pone.0173944.ref058">58</xref>]. The true penetrance of PD in adults with 22q11.2DS remains to be reliably estimated, and there are as yet no predictive clinical markers of PD. Longitudinal studies will help resolve such questions. For the six cases without PD, all but one (NPD1) had reached or was beyond the reported age-at-onset range for 22q11.2DS-associated early-onset PD [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0173944.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0173944.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0173944.ref046">46</xref>]. The absence of PD pathology was confirmed in one case where brain tissue was available (NPD4) [<xref ref-type="bibr" rid="pone.0173944.ref002">2</xref>], and there was no evidence of nigrostriatal dopamine loss in two others (NPD1 and NPD6) on PET neuroimaging using <sup>11</sup>C-dihydrotetrabenazine relative to controls [<xref ref-type="bibr" rid="pone.0173944.ref058">58</xref>, <xref ref-type="bibr" rid="pone.0173944.ref059">59</xref>].</p>
<p>The results of this study represent an important first step in appreciating how WGS can help to elucidate the genetic etiology of early-onset PD in 22q11.2DS. These findings may have implications for other genetic models of PD and for idiopathic PD. Eventually such molecular results could help to inform early identification and intervention strategies for individuals at risk.</p>
</sec>
<sec id="sec015" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pone.0173944.s001">
<label>S1 Fig</label>
<caption>
<title>Distribution boxplots of polygenic risk scores for patients with 22q11.2 deletion syndrome and Parkinson’s disease (22q11.2DS-PD) and those without Parkinson’s disease (22q11.2DS-NPD).</title>
<p>The mean polygenic score (open diamond) is non-significantly greater in the 22q11.2DS-PD group than the 22q11.2DS-NPD group (<italic>p</italic> = 0.17) at the most stringent <italic>p</italic>-value threshold (left panel, (≤1e<sup>-7</sup>). This pattern was not observed at lower <italic>p-</italic>value thresholds (e.g., ≤1e<sup>-3</sup>) shown here in the right panel for comparison purposes). See <xref ref-type="sec" rid="sec006">Methods</xref> for details.</p>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0173944.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0173944.s002">
<label>S1 Table</label>
<caption>
<title>List of 43 putative candidate genes implicated in Parkinson’s disease.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0173944.s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0173944.s003">
<label>S2 Table</label>
<caption>
<title>List of genes in Parkinson’s disease-relevant gene-sets.</title>
<p>(XLSX)</p>
</caption>
<media xlink:href="pone.0173944.s003.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0173944.s004">
<label>S3 Table</label>
<caption>
<title>22q11.2 deletion breakpoints of individuals with 22q11.2 deletion syndrome with whole-genome sequencing results.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0173944.s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We acknowledge the investigators of the original study [<xref ref-type="bibr" rid="pone.0173944.ref023">23</xref>] and PDGene [<xref ref-type="bibr" rid="pone.0173944.ref024">24</xref>] for sharing the GWAS genetics data used for polygenic score analyses. We thank Dr. Daniele Andrade (Epilepsy Genetics Program, University Health Network, Toronto, Canada) for contributing genetic data. We would also like to thank Thomas Nalpathamkalam and Bhooma Thiruvahindrapuram (The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada), and Phil Fradkin (Clinical Genetics Research Program, Centre for Addiction and Mental Health) for assistance with genetic data processing and analyses. We thank the staff of Clinical Genetics Research Program and the Dalglish 22q Clinic for Adults with 22q11.2 Deletion Syndrome for study support.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0173944.ref001">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>C</given-names></name>, <name><surname>Westenberger</surname><given-names>A</given-names></name>. <article-title>Genetics of Parkinson's disease</article-title>. <source/>Cold Spring Harb Perspect Med. <year>2012</year>;<volume>2</volume>: <fpage>a008888</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a008888">10.1101/cshperspect.a008888</ext-link></comment>
<pub-id pub-id-type="pmid">22315721</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Butcher</surname><given-names>N</given-names></name>, <name><surname>Kiehl</surname><given-names>T</given-names></name>, <name><surname>Hazrati</surname><given-names>L</given-names></name>, <name><surname>Chow</surname><given-names>E</given-names></name>, <name><surname>Rogaeva</surname><given-names>E</given-names></name>, <name><surname>Lang</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: Identification of a novel genetic form of Parkinson disease and its clinical implications</article-title>. <source/>JAMA Neurology. <year>2013</year>;<volume>70</volume>: <fpage>1359</fpage>–<lpage>1366</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jamaneurol.2013.3646">10.1001/jamaneurol.2013.3646</ext-link></comment>
<pub-id pub-id-type="pmid">24018986</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Mok</surname><given-names>KY</given-names></name>, <name><surname>Sheerin</surname><given-names>U</given-names></name>, <name><surname>Simon-Sanchez</surname><given-names>J</given-names></name>, <name><surname>Salaka</surname><given-names>A</given-names></name>, <name><surname>Chester</surname><given-names>L</given-names></name>, <name><surname>Escott-Price</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data</article-title>. <source/>Lancet Neurol. <year>2016</year>;<volume>15</volume>: <fpage>585</fpage>–<lpage>596</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1474-4422(16)00071-5">10.1016/S1474-4422(16)00071-5</ext-link></comment>
<pub-id pub-id-type="pmid">27017469</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Zarrei</surname><given-names>M</given-names></name>, <name><surname>Costain</surname><given-names>G</given-names></name>, <name><surname>Ogura</surname><given-names>L</given-names></name>, <name><surname>Alipanahi</surname><given-names>B</given-names></name>, <name><surname>Gazzellone</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>Whole-genome sequencing suggests schizophrenia risk mechanisms in humans with 22q11.2 deletion syndrome</article-title>. <source/>G3 (Bethesda). <year>2015</year>;<volume>5</volume>: <fpage>2453</fpage>–<lpage>2461</lpage>.<pub-id pub-id-type="pmid">26384369</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Bassett</surname><given-names>AS</given-names></name>, <name><surname>Chow</surname><given-names>EW</given-names></name>, <name><surname>AbdelMalik</surname><given-names>P</given-names></name>, <name><surname>Gheorghiu</surname><given-names>M</given-names></name>, <name><surname>Husted</surname><given-names>J</given-names></name>, <name><surname>Weksberg</surname><given-names>R</given-names></name>. <article-title>The schizophrenia phenotype in 22q11 deletion syndrome</article-title>. <source/>Am J Psychiatry. <year>2003</year>;<volume>160</volume>: <fpage>1580</fpage>–<lpage>1586</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1176/appi.ajp.160.9.1580">10.1176/appi.ajp.160.9.1580</ext-link></comment>
<pub-id pub-id-type="pmid">12944331</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Bassett</surname><given-names>AS</given-names></name>, <name><surname>Marshall</surname><given-names>CR</given-names></name>, <name><surname>Lionel</surname><given-names>AC</given-names></name>, <name><surname>Chow</surname><given-names>EW</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name>. <article-title>Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome</article-title>. <source/>Hum Mol Genet. <year>2008</year>;<volume>17</volume>: <fpage>4045</fpage>–<lpage>4053</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddn307">10.1093/hmg/ddn307</ext-link></comment>
<pub-id pub-id-type="pmid">18806272</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Butcher</surname><given-names>N</given-names></name>, <name><surname>Chow</surname><given-names>E</given-names></name>, <name><surname>Costain</surname><given-names>G</given-names></name>, <name><surname>Karas</surname><given-names>D</given-names></name>, <name><surname>Ho</surname><given-names>A</given-names></name>, <name><surname>Bassett</surname><given-names>A</given-names></name>. <article-title>Functional outcomes of adults with 22q11.2 deletion syndrome</article-title>. <source/>Genet Med. <year>2012</year>;<volume>14</volume>: <fpage>836</fpage>–<lpage>843</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/gim.2012.66">10.1038/gim.2012.66</ext-link></comment>
<pub-id pub-id-type="pmid">22744446</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Van</surname><given-names>L</given-names></name>, <name><surname>Butcher</surname><given-names>NJ</given-names></name>, <name><surname>Costain</surname><given-names>G</given-names></name>, <name><surname>Ogura</surname><given-names>L</given-names></name>, <name><surname>Chow</surname><given-names>EW</given-names></name>, <name><surname>Bassett</surname><given-names>AS</given-names></name>. <article-title>Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome</article-title>. <source/>Genet Med. <year>2016</year>;<volume>18</volume>: <fpage>350</fpage>–<lpage>355</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/gim.2015.84">10.1038/gim.2015.84</ext-link></comment>
<pub-id pub-id-type="pmid">26087175</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Yuen</surname><given-names>RK</given-names></name>, <name><surname>Thiruvahindrapuram</surname><given-names>B</given-names></name>, <name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Walker</surname><given-names>S</given-names></name>, <name><surname>Tammimies</surname><given-names>K</given-names></name>, <name><surname>Hoang</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Whole-genome sequencing of quartet families with autism spectrum disorder</article-title>. <source/>Nat Med. <year>2015</year>;<volume>21</volume>: <fpage>185</fpage>–<lpage>191</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.3792">10.1038/nm.3792</ext-link></comment>
<pub-id pub-id-type="pmid">25621899</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Kiehl</surname><given-names>TR</given-names></name>, <name><surname>Chow</surname><given-names>EWC</given-names></name>, <name><surname>Mikulis</surname><given-names>DJ</given-names></name>, <name><surname>George</surname><given-names>SR</given-names></name>, <name><surname>Bassett</surname><given-names>AS</given-names></name>. <article-title>Neuropathologic features in adults with 22q11.2 deletion syndrome</article-title>. <source/>Cereb Cortex. <year>2009</year>;<volume>19</volume>: <fpage>153</fpage>–<lpage>164</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cercor/bhn066">10.1093/cercor/bhn066</ext-link></comment>
<pub-id pub-id-type="pmid">18483005</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source/>Nucleic Acids Res. <year>2010</year>;<volume>38</volume>: <fpage>e164</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkq603">10.1093/nar/gkq603</ext-link></comment>
<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Genomes Project</surname><given-names>C</given-names></name>, <name><surname>Auton</surname><given-names>A</given-names></name>, <name><surname>Brooks</surname><given-names>LD</given-names></name>, <name><surname>Durbin</surname><given-names>RM</given-names></name>, <name><surname>Garrison</surname><given-names>EP</given-names></name>, <name><surname>Kang</surname><given-names>HM</given-names></name>, <etal>et al</etal>
<article-title>A global reference for human genetic variation</article-title>. <source/>Nature. <year>2015</year>;<volume>526</volume>: <fpage>68</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature15393">10.1038/nature15393</ext-link></comment>
<pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Tennessen</surname><given-names>JA</given-names></name>, <name><surname>Bigham</surname><given-names>AW</given-names></name>, <name><surname>O'Connor</surname><given-names>TD</given-names></name>, <name><surname>Fu</surname><given-names>W</given-names></name>, <name><surname>Kenny</surname><given-names>EE</given-names></name>, <name><surname>Gravel</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Evolution and functional impact of rare coding variation from deep sequencing of human exomes</article-title>. <source/>Science. <year>2012</year>;<volume>337</volume>: <fpage>64</fpage>–<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1219240">10.1126/science.1219240</ext-link></comment>
<pub-id pub-id-type="pmid">22604720</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature. <year>2016</year>;<volume>536</volume>: <fpage>285</fpage>–<lpage>291</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature19057">10.1038/nature19057</ext-link></comment>
<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Pollard</surname><given-names>KS</given-names></name>, <name><surname>Hubisz</surname><given-names>MJ</given-names></name>, <name><surname>Rosenbloom</surname><given-names>KR</given-names></name>, <name><surname>Siepel</surname><given-names>A</given-names></name>. <article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>. <source/>Genome Res. <year>2010</year>;<volume>20</volume>: <fpage>110</fpage>–<lpage>121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.097857.109">10.1101/gr.097857.109</ext-link></comment>
<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>PC</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>. <article-title>Predicting deleterious amino acid substitutions</article-title>. <source/>Genome Res. <year>2001</year>;<volume>11</volume>: <fpage>863</fpage>–<lpage>874</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.176601">10.1101/gr.176601</ext-link></comment>
<pub-id pub-id-type="pmid">11337480</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods. <year>2010</year>;<volume>7</volume>: <fpage>248</fpage>–<lpage>249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth0410-248">10.1038/nmeth0410-248</ext-link></comment>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Reva</surname><given-names>B</given-names></name>, <name><surname>Antipin</surname><given-names>Y</given-names></name>, <name><surname>Sander</surname><given-names>C</given-names></name>. <article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title>. <source/>Nucleic Acids Res. <year>2011</year>;<volume>39</volume>: <fpage>e118</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkr407">10.1093/nar/gkr407</ext-link></comment>
<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>, <name><surname>Witten</surname><given-names>DM</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>O'Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source/>Nat Genet. <year>2014</year>;<volume>46</volume>: <fpage>310</fpage>–<lpage>315</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2892">10.1038/ng.2892</ext-link></comment>
<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>JM</given-names></name>, <name><surname>Cooper</surname><given-names>DN</given-names></name>, <name><surname>Schuelke</surname><given-names>M</given-names></name>, <name><surname>Seelow</surname><given-names>D</given-names></name>. <article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>. <source/>Nat Methods. <year>2014</year>;<volume>11</volume>: <fpage>361</fpage>–<lpage>362</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth.2890">10.1038/nmeth.2890</ext-link></comment>
<pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Ogaki</surname><given-names>K</given-names></name>, <name><surname>Ross</surname><given-names>OA</given-names></name>. <article-title>Chromosome 22q11.2 deletion may contain a locus for recessive early-onset Parkinson's disease</article-title>. <source/>Parkinsonism Relat Disord. <year>2014</year>;<volume>20</volume>: <fpage>945</fpage>–<lpage>946</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.parkreldis.2014.06.020">10.1016/j.parkreldis.2014.06.020</ext-link></comment>
<pub-id pub-id-type="pmid">25001314</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Guna</surname><given-names>A</given-names></name>, <name><surname>Butcher</surname><given-names>NJ</given-names></name>, <name><surname>Bassett</surname><given-names>AS</given-names></name>. <article-title>Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms</article-title>. <source/>J Neurodev Disord. <year>2015</year>;<volume>7</volume>: <fpage>18</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s11689-015-9113-x">10.1186/s11689-015-9113-x</ext-link></comment>
<pub-id pub-id-type="pmid">26137170</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Nalls</surname><given-names>MA</given-names></name>, <name><surname>Pankratz</surname><given-names>N</given-names></name>, <name><surname>Lill</surname><given-names>CM</given-names></name>, <name><surname>Do</surname><given-names>CB</given-names></name>, <name><surname>Hernandez</surname><given-names>DG</given-names></name>, <name><surname>Saad</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease</article-title>. <source/>Nat Genet. <year>2014</year>;<volume>46</volume>: <fpage>989</fpage>–<lpage>993</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.3043">10.1038/ng.3043</ext-link></comment>
<pub-id pub-id-type="pmid">25064009</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Lill</surname><given-names>CM</given-names></name>, <name><surname>Roehr</surname><given-names>JT</given-names></name>, <name><surname>McQueen</surname><given-names>MB</given-names></name>, <name><surname>Kavvoura</surname><given-names>FK</given-names></name>, <name><surname>Bagade</surname><given-names>S</given-names></name>, <name><surname>Schjeide</surname><given-names>BM</given-names></name>, <etal>et al</etal>
<article-title>Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database</article-title>. <source/>PLoS Genet. <year>2012</year>;<volume>8</volume>: <fpage>e1002548</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1002548">10.1371/journal.pgen.1002548</ext-link></comment>
<pub-id pub-id-type="pmid">22438815</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Spataro</surname><given-names>N</given-names></name>, <name><surname>Calafell</surname><given-names>F</given-names></name>, <name><surname>Cervera-Carles</surname><given-names>L</given-names></name>, <name><surname>Casals</surname><given-names>F</given-names></name>, <name><surname>Pagonabarraga</surname><given-names>J</given-names></name>, <name><surname>Pascual-Sedano</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Mendelian genes for Parkinson's disease contribute to the sporadic forms of the disease</article-title>. <source/>Hum Mol Genet. <year>2015</year>;<volume>24</volume>: <fpage>2023</fpage>–<lpage>2034</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddu616">10.1093/hmg/ddu616</ext-link></comment>
<pub-id pub-id-type="pmid">25504046</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Aerts</surname><given-names>S</given-names></name>, <name><surname>Lambrechts</surname><given-names>D</given-names></name>, <name><surname>Maity</surname><given-names>S</given-names></name>, <name><surname>Van Loo</surname><given-names>P</given-names></name>, <name><surname>Coessens</surname><given-names>B</given-names></name>, <name><surname>De Smet</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Gene prioritization through genomic data fusion</article-title>. <source/>Nat Biotechnol. <year>2006</year>;<volume>24</volume>: <fpage>537</fpage>–<lpage>544</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt1203">10.1038/nbt1203</ext-link></comment>
<pub-id pub-id-type="pmid">16680138</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name><surname>Ardeshirdavani</surname><given-names>A</given-names></name>, <name><surname>ElShal</surname><given-names>S</given-names></name>, <name><surname>Alcaide</surname><given-names>D</given-names></name>, <name><surname>Aerts</surname><given-names>J</given-names></name>, <name><surname>Auboeuf</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Candidate gene prioritization with Endeavour</article-title>. <source/>Nucleic Acids Res. <year>2016</year>;<volume>44</volume>: <fpage>W117</fpage>–<lpage>121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkw365">10.1093/nar/gkw365</ext-link></comment>
<pub-id pub-id-type="pmid">27131783</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name><surname>Barriot</surname><given-names>R</given-names></name>, <name><surname>Yu</surname><given-names>S</given-names></name>, <name><surname>Van Vooren</surname><given-names>S</given-names></name>, <name><surname>Van Loo</surname><given-names>P</given-names></name>, <name><surname>Coessens</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>ENDEAVOUR update: a web resource for gene prioritization in multiple species</article-title>. <source/>Nucleic Acids Res. <year>2008</year>;<volume>36</volume>: <fpage>W377</fpage>–<lpage>384</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkn325">10.1093/nar/gkn325</ext-link></comment>
<pub-id pub-id-type="pmid">18508807</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Son</surname><given-names>CG</given-names></name>, <name><surname>Bilke</surname><given-names>S</given-names></name>, <name><surname>Davis</surname><given-names>S</given-names></name>, <name><surname>Greer</surname><given-names>BT</given-names></name>, <name><surname>Wei</surname><given-names>JS</given-names></name>, <name><surname>Whiteford</surname><given-names>CC</given-names></name>, <etal>et al</etal>
<article-title>Database of mRNA gene expression profiles of multiple human organs</article-title>. <source/>Genome Res. <year>2005</year>;<volume>15</volume>: <fpage>443</fpage>–<lpage>450</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.3124505">10.1101/gr.3124505</ext-link></comment>
<pub-id pub-id-type="pmid">15741514</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Gene Ontology</surname><given-names>C</given-names></name>, <name><surname>Blake</surname><given-names>JA</given-names></name>, <name><surname>Dolan</surname><given-names>M</given-names></name>, <name><surname>Drabkin</surname><given-names>H</given-names></name>, <name><surname>Hill</surname><given-names>DP</given-names></name>, <name><surname>Li</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Gene Ontology annotations and resources</article-title>. <source/>Nucleic Acids Res. <year>2013</year>;<volume>41</volume>: <fpage>D530</fpage>–<lpage>535</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gks1050">10.1093/nar/gks1050</ext-link></comment>
<pub-id pub-id-type="pmid">23161678</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>International Schizophrenia</surname><given-names>C</given-names></name>, <name><surname>Purcell</surname><given-names>SM</given-names></name>, <name><surname>Wray</surname><given-names>NR</given-names></name>, <name><surname>Stone</surname><given-names>JL</given-names></name>, <name><surname>Visscher</surname><given-names>PM</given-names></name>, <name><surname>O'Donovan</surname><given-names>MC</given-names></name>, <etal>et al</etal>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>. <source/>Nature. <year>2009</year>;<volume>460</volume>: <fpage>748</fpage>–<lpage>752</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature08185">10.1038/nature08185</ext-link></comment>
<pub-id pub-id-type="pmid">19571811</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Bassett</surname><given-names>AS</given-names></name>, <name><surname>McDonald-McGinn</surname><given-names>DM</given-names></name>, <name><surname>Devriendt</surname><given-names>K</given-names></name>, <name><surname>Digilio</surname><given-names>MC</given-names></name>, <name><surname>Goldenberg</surname><given-names>P</given-names></name>, <name><surname>Habel</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Practical guidelines for managing patients with 22q11.2 deletion syndrome</article-title>. <source/>J Pediatr. <year>2011</year>;<volume>159</volume>: <fpage>332</fpage>–<lpage>339</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpeds.2011.02.039">10.1016/j.jpeds.2011.02.039</ext-link></comment>
<pub-id pub-id-type="pmid">21570089</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Fung</surname><given-names>WL</given-names></name>, <name><surname>Butcher</surname><given-names>NJ</given-names></name>, <name><surname>Costain</surname><given-names>G</given-names></name>, <name><surname>Andrade</surname><given-names>DM</given-names></name>, <name><surname>Boot</surname><given-names>E</given-names></name>, <name><surname>Chow</surname><given-names>EW</given-names></name>, <etal>et al</etal>
<article-title>Practical guidelines for managing adults with 22q11.2 deletion syndrome</article-title>. <source/>Genet Med. <year>2015</year>;<volume>17</volume>: <fpage>599</fpage>–<lpage>609</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/gim.2014.175">10.1038/gim.2014.175</ext-link></comment>
<pub-id pub-id-type="pmid">25569435</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>McDonald-McGinn</surname><given-names>DM</given-names></name>, <name><surname>Sullivan</surname><given-names>KE</given-names></name>, <name><surname>Marino</surname><given-names>B</given-names></name>, <name><surname>Philip</surname><given-names>N</given-names></name>, <name><surname>Swillen</surname><given-names>A</given-names></name>, <name><surname>Vorstman</surname><given-names>JAS</given-names></name>, <etal>et al</etal>
<article-title>22q11.2 deletion syndrome</article-title>. <source/>Nature Reviews Disease Primers. <year>2015</year>;<volume>1</volume>: <fpage>15071</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrdp.2015.71">10.1038/nrdp.2015.71</ext-link></comment>
<pub-id pub-id-type="pmid">27189754</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Hicks</surname><given-names>DG</given-names></name>, <name><surname>Janarthanan</surname><given-names>BR</given-names></name>, <name><surname>Vardarajan</surname><given-names>R</given-names></name>, <name><surname>Kulkarni</surname><given-names>SA</given-names></name>, <name><surname>Khoury</surname><given-names>T</given-names></name>, <name><surname>Dim</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence</article-title>. <source/>BMC Cancer. <year>2010</year>;<volume>10</volume>: <fpage>108</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2407-10-108">10.1186/1471-2407-10-108</ext-link></comment>
<pub-id pub-id-type="pmid">20307320</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Kajiwara</surname><given-names>K</given-names></name>, <name><surname>Nagasawa</surname><given-names>H</given-names></name>, <name><surname>Shimizu-Nishikawa</surname><given-names>K</given-names></name>, <name><surname>Ookura</surname><given-names>T</given-names></name>, <name><surname>Kimura</surname><given-names>M</given-names></name>, <name><surname>Sugaya</surname><given-names>E</given-names></name>. <article-title>Cloning of SEZ-12 encoding seizure-related and membrane-bound adhesion protein</article-title>. <source/>Biochem Biophys Res Commun. <year>1996</year>;<volume>222</volume>: <fpage>144</fpage>–<lpage>148</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/bbrc.1996.0712">10.1006/bbrc.1996.0712</ext-link></comment>
<pub-id pub-id-type="pmid">8630060</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Ou</surname><given-names>XM</given-names></name>, <name><surname>Chen</surname><given-names>K</given-names></name>, <name><surname>Shih</surname><given-names>JC</given-names></name>. <article-title>Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene</article-title>. <source/>J Biol Chem. <year>2004</year>;<volume>279</volume>: <fpage>21021</fpage>–<lpage>21028</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M312638200">10.1074/jbc.M312638200</ext-link></comment>
<pub-id pub-id-type="pmid">15024015</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>D'Andrea</surname><given-names>MR</given-names></name>, <name><surname>Ilyin</surname><given-names>S</given-names></name>, <name><surname>Plata-Salaman</surname><given-names>CR</given-names></name>. <article-title>Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues</article-title>. <source/>Neurosci Lett. <year>2001</year>;<volume>306</volume>: <fpage>137</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="pmid">11406314</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Simunovic</surname><given-names>F</given-names></name>, <name><surname>Yi</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Macey</surname><given-names>L</given-names></name>, <name><surname>Brown</surname><given-names>LT</given-names></name>, <name><surname>Krichevsky</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology</article-title>. <source/>Brain. <year>2009</year>;<volume>132</volume>: <fpage>1795</fpage>–<lpage>1809</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/brain/awn323">10.1093/brain/awn323</ext-link></comment>
<pub-id pub-id-type="pmid">19052140</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Chauveau</surname><given-names>C</given-names></name>, <name><surname>Rowell</surname><given-names>J</given-names></name>, <name><surname>Ferreiro</surname><given-names>A</given-names></name>. <article-title>A rising titan: TTN review and mutation update</article-title>. <source/>Hum Mutat. <year>2014</year>;<volume>35</volume>: <fpage>1046</fpage>–<lpage>1059</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.22611">10.1002/humu.22611</ext-link></comment>
<pub-id pub-id-type="pmid">24980681</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Lubbe</surname><given-names>SJ</given-names></name>, <name><surname>Escott-Price</surname><given-names>V</given-names></name>, <name><surname>Gibbs</surname><given-names>JR</given-names></name>, <name><surname>Nalls</surname><given-names>MA</given-names></name>, <name><surname>Bras</surname><given-names>J</given-names></name>, <name><surname>Price</surname><given-names>TR</given-names></name>, <etal>et al</etal>
<article-title>Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance</article-title>. <source/>Hum Mol Genet. <year>2016</year>.</mixed-citation>
</ref>
<ref id="pone.0173944.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Rehman</surname><given-names>AF</given-names></name>, <name><surname>Dhamija</surname><given-names>R</given-names></name>, <name><surname>Williams</surname><given-names>ES</given-names></name>, <name><surname>Barrett</surname><given-names>MJ</given-names></name>. <article-title>22q11.2 deletion syndrome presenting with early-onset Parkinson's disease</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>: <fpage>1289</fpage>–<lpage>1290</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mds.26305">10.1002/mds.26305</ext-link></comment>
<pub-id pub-id-type="pmid">26195290</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Verhoeven</surname><given-names>WM</given-names></name>, <name><surname>Egger</surname><given-names>JI</given-names></name>. <article-title>Atypical antipsychotics and relapsing psychoses in 22q11.2 deletion syndrome: A long-term evaluation of 28 patients</article-title>. <source/>Pharmacopsychiatry. <year>2015</year>;Epub: Feb 5th 2015.</mixed-citation>
</ref>
<ref id="pone.0173944.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Zaleski</surname><given-names>C</given-names></name>, <name><surname>Bassett</surname><given-names>AS</given-names></name>, <name><surname>Tam</surname><given-names>K</given-names></name>, <name><surname>Shugar</surname><given-names>AL</given-names></name>, <name><surname>Chow</surname><given-names>EW</given-names></name>, <name><surname>McPherson</surname><given-names>E</given-names></name>. <article-title>The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome</article-title>. <source/>Am J Med Genet A. <year>2009</year>;<volume>149A</volume>: <fpage>525</fpage>–<lpage>528</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.a.32650">10.1002/ajmg.a.32650</ext-link></comment>
<pub-id pub-id-type="pmid">19208384</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Booij</surname><given-names>J</given-names></name>, <name><surname>van Amelsvoort</surname><given-names>T</given-names></name>, <name><surname>Boot</surname><given-names>E</given-names></name>. <article-title>Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging</article-title>. <source/>Am J Med Genet A. <year>2010</year>;<volume>152A</volume>: <fpage>2937</fpage>–<lpage>2938</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.a.33665">10.1002/ajmg.a.33665</ext-link></comment>
<pub-id pub-id-type="pmid">20949509</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Oki</surname><given-names>M</given-names></name>, <name><surname>Hori</surname><given-names>S</given-names></name>, <name><surname>Asayama</surname><given-names>S</given-names></name>, <name><surname>Wate</surname><given-names>R</given-names></name>, <name><surname>Kaneko</surname><given-names>S</given-names></name>, <name><surname>Kusaka</surname><given-names>H</given-names></name>. <article-title>Early-onset Parkinson's disease associated with chromosome 22q11.2 deletion syndrome</article-title>. <source/>Intern Med. <year>2016</year>;<volume>55</volume>: <fpage>303</fpage>–<lpage>305</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2169/internalmedicine.55.5485">10.2169/internalmedicine.55.5485</ext-link></comment>
<pub-id pub-id-type="pmid">26831029</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Foo</surname><given-names>JN</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Tan</surname><given-names>LC</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Tan</surname><given-names>EK</given-names></name>. <article-title>Large 3-Mb deletions at 22q11.2 locus in Parkinson's disease and schizophrenia</article-title>. <source/>Mov Disord. <year>2016</year>;<volume>31</volume>: <fpage>1924</fpage>–<lpage>1925</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mds.26822">10.1002/mds.26822</ext-link></comment>
<pub-id pub-id-type="pmid">27787935</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Pollard</surname><given-names>R</given-names></name>, <name><surname>Hannan</surname><given-names>M</given-names></name>, <name><surname>Tanabe</surname><given-names>J</given-names></name>, <name><surname>Berman</surname><given-names>BD</given-names></name>. <article-title>Early-onset Parkinson disease leading to diagnosis of 22q11.2 deletion syndrome</article-title>. <source/>Parkinsonism Relat Disord. <year>2016</year>;<volume>25</volume>: <fpage>110</fpage>–<lpage>111</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.parkreldis.2016.01.027">10.1016/j.parkreldis.2016.01.027</ext-link></comment>
<pub-id pub-id-type="pmid">26868161</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Vogels</surname><given-names>A</given-names></name>, <name><surname>Verhoeven</surname><given-names>WM</given-names></name>, <name><surname>Tuinier</surname><given-names>S</given-names></name>, <name><surname>DeVriendt</surname><given-names>K</given-names></name>, <name><surname>Swillen</surname><given-names>A</given-names></name>, <name><surname>Curfs</surname><given-names>LM</given-names></name>, <etal>et al</etal>
<article-title>The psychopathological phenotype of velo-cardio-facial syndrome</article-title>. <source/>Ann Genet. <year>2002</year>;<volume>45</volume>: <fpage>89</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="pmid">12119217</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Edelmann</surname><given-names>L</given-names></name>, <name><surname>Pandita</surname><given-names>RK</given-names></name>, <name><surname>Morrow</surname><given-names>BE</given-names></name>. <article-title>Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome</article-title>. <source/>Am J Hum Genet. <year>1999</year>;<volume>64</volume>: <fpage>1076</fpage>–<lpage>1086</lpage>. <pub-id pub-id-type="pmid">10090893</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Shaikh</surname><given-names>TH</given-names></name>, <name><surname>Kurahashi</surname><given-names>H</given-names></name>, <name><surname>Saitta</surname><given-names>SC</given-names></name>, <name><surname>O'Hare</surname><given-names>AM</given-names></name>, <name><surname>Hu</surname><given-names>P</given-names></name>, <name><surname>Roe</surname><given-names>BA</given-names></name>, <etal>et al</etal>
<article-title>Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis</article-title>. <source/>Hum Mol Genet. <year>2000</year>;<volume>9</volume>: <fpage>489</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="pmid">10699172</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Gothelf</surname><given-names>D</given-names></name>, <name><surname>Schaer</surname><given-names>M</given-names></name>, <name><surname>Eliez</surname><given-names>S</given-names></name>. <article-title>Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome</article-title>. <source/>Develop Disabil Res Rev. <year>2008</year>;<volume>14</volume>: <fpage>59</fpage>–<lpage>68</lpage>.</mixed-citation>
</ref>
<ref id="pone.0173944.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Weksberg</surname><given-names>R</given-names></name>, <name><surname>Stachon</surname><given-names>AC</given-names></name>, <name><surname>Squire</surname><given-names>JA</given-names></name>, <name><surname>Moldovan</surname><given-names>L</given-names></name>, <name><surname>Bayani</surname><given-names>J</given-names></name>, <name><surname>Meyn</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome</article-title>. <source/>Hum Genet. <year>2007</year>;<volume>120</volume>: <fpage>837</fpage>–<lpage>845</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00439-006-0242-x">10.1007/s00439-006-0242-x</ext-link></comment>
<pub-id pub-id-type="pmid">17028864</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref054">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Karayiorgou</surname><given-names>M</given-names></name>, <name><surname>Simon</surname><given-names>TJ</given-names></name>, <name><surname>Gogos</surname><given-names>JA</given-names></name>. <article-title>22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia</article-title>. <source/>Nat Rev Neurosci. <year>2010</year>;<volume>11</volume>: <fpage>402</fpage>–<lpage>416</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrn2841">10.1038/nrn2841</ext-link></comment>
<pub-id pub-id-type="pmid">20485365</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Evatt</surname><given-names>ML</given-names></name>, <name><surname>Maldonado</surname><given-names>LG</given-names></name>, <name><surname>Perry</surname><given-names>WR</given-names></name>, <name><surname>Ritchie</surname><given-names>JC</given-names></name>, <name><surname>Beecham</surname><given-names>GW</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D from different sources is inversely associated with Parkinson disease</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>: <fpage>560</fpage>–<lpage>566</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mds.26117">10.1002/mds.26117</ext-link></comment>
<pub-id pub-id-type="pmid">25545356</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Kelley</surname><given-names>L</given-names></name>, <name><surname>Sanders</surname><given-names>AF</given-names></name>, <name><surname>Beaton</surname><given-names>EA</given-names></name>. <article-title>Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome</article-title>. <source/>J Dev Orig Health Dis. <year>2016</year>;<volume>7</volume>: <fpage>616</fpage>–<lpage>625</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S2040174416000428">10.1017/S2040174416000428</ext-link></comment>
<pub-id pub-id-type="pmid">27827293</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Costain</surname><given-names>G</given-names></name>, <name><surname>Butcher</surname><given-names>NJ</given-names></name>, <name><surname>Warnica</surname><given-names>W</given-names></name>, <name><surname>Ogura</surname><given-names>L</given-names></name>, <name><surname>Alfred</surname><given-names>SE</given-names></name>, <etal>et al</etal>
<article-title>MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome</article-title>. <source/>Front Neurol. <year>2014</year>;<volume>5</volume>: <fpage>238</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2014.00238">10.3389/fneur.2014.00238</ext-link></comment>
<pub-id pub-id-type="pmid">25484875</pub-id></mixed-citation>
</ref>
<ref id="pone.0173944.ref058">
<label>58</label>
<mixed-citation publication-type="other">Butcher N, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, et al. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease Brain. 2017; Forthcoming.</mixed-citation>
</ref>
<ref id="pone.0173944.ref059">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Butcher</surname><given-names>N</given-names></name>, <name><surname>Marras</surname><given-names>C</given-names></name>, <name><surname>Pondal</surname><given-names>M</given-names></name>, <name><surname>Rusjan</surname><given-names>P</given-names></name>, <name><surname>Christopher</surname><given-names>L</given-names></name>, <name><surname>Strafella</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Investigating prodromal markers of Parkinson’s disease in adults with hemizygous 22q11.2 deletions</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume> (<issue>S1</issue>): <fpage>S1035</fpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>